AptaBio Therapeutics (Korea) Analysis
| 293780 Stock | 6,520 210.00 3.12% |
AptaBio Therapeutics is overvalued with Real Value of 6178.2 and Hype Value of 6520.0. The main objective of AptaBio Therapeutics stock analysis is to determine its intrinsic value, which is an estimate of what AptaBio Therapeutics is worth, separate from its market price. There are two main types of AptaBio Therapeutics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect AptaBio Therapeutics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of AptaBio Therapeutics' stock to identify patterns and trends that may indicate its future price movements.
The AptaBio Therapeutics stock is traded in Korea on KOSDAQ, with the market opening at 09:00:00 and closing at 15:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Korea. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and AptaBio Therapeutics' ongoing operational relationships across important fundamental and technical indicators.
AptaBio |
AptaBio Stock Analysis Notes
About 34.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. AptaBio Therapeutics had 2:1 split on the 24th of August 2021. For more info on AptaBio Therapeutics please contact the company at 82 70 7152 0097 or go to http://www.aptabio.com.AptaBio Therapeutics Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. AptaBio Therapeutics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding AptaBio Therapeutics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| AptaBio Therapeutics generated a negative expected return over the last 90 days | |
| AptaBio Therapeutics has high historical volatility and very poor performance | |
| The company reported the revenue of 223.68 M. Net Loss for the year was (10.69 B) with profit before overhead, payroll, taxes, and interest of 336.97 M. | |
| AptaBio Therapeutics has accumulated about 6.57 B in cash with (8.9 B) of positive cash flow from operations. | |
| Roughly 34.0% of the company shares are owned by insiders or employees |
AptaBio Market Capitalization
The company currently falls under 'Mega-Cap' category with a current market capitalization of 111.21 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AptaBio Therapeutics's market, we take the total number of its shares issued and multiply it by AptaBio Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 1st of December, AptaBio Therapeutics shows the Standard Deviation of 4.05, risk adjusted performance of (0.03), and Mean Deviation of 3.07. AptaBio Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.AptaBio Therapeutics Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. AptaBio Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for AptaBio Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
AptaBio Therapeutics Outstanding Bonds
AptaBio Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. AptaBio Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most AptaBio bonds can be classified according to their maturity, which is the date when AptaBio Therapeutics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
AptaBio Therapeutics Predictive Daily Indicators
AptaBio Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of AptaBio Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 0.0512 | |||
| Daily Balance Of Power | (0.60) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 6655.0 | |||
| Day Typical Price | 6610.0 | |||
| Market Facilitation Index | 350.0 | |||
| Price Action Indicator | (240.00) | |||
| Period Momentum Indicator | (210.00) | |||
| Relative Strength Index | 23.16 |
AptaBio Therapeutics Forecast Models
AptaBio Therapeutics' time-series forecasting models are one of many AptaBio Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary AptaBio Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding AptaBio Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run AI Portfolio Architect Now
AI Portfolio ArchitectUse AI to generate optimal portfolios and find profitable investment opportunities |
| All Next | Launch Module |
Complementary Tools for AptaBio Stock analysis
When running AptaBio Therapeutics' price analysis, check to measure AptaBio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AptaBio Therapeutics is operating at the current time. Most of AptaBio Therapeutics' value examination focuses on studying past and present price action to predict the probability of AptaBio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AptaBio Therapeutics' price. Additionally, you may evaluate how the addition of AptaBio Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |